Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 15 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
141 30.0 months Advanced breast cancer Hormone
Rigshospitalet Denmark 6/2003
Treatment Details: Patients: This Phase III study involved 916 advanced breast cancer patients (postmenopausal) with hormone-receptor positive or unknown tumors. Patients were divided into two groups: Group 1
 
142 29.9 months Metastatic Colorectal Cancer 4 Chemotherapy
Shizuoka Cancer Center Japan 1/2015
Treatment Details: Patients: This phase 2 study involved metastatic colorectal cancer patients who had not received prior chemotherapy. Patients were divided into two separate treatment groups. Group A had 5
 
143 29.7 months Hepatocellular carcinoma 4 Biologic therapy
Kinki University School of Medicine Japan 9/2011
Treatment Details: Patients: This phase III involved 229 hepatocellular carcinoma (HCC) patients who had been previously treated with epirubicin, cisplatin, doxorubicin, and/or mitomycin. The median patient
 
144 29.6 months Ovarian cancer (no evidence of disease) 4 Immunotherapy
Vaccine Branch, CCR, NCI United States 9/2011
Treatment Details: Patients: This study involved women with ovarian cancer and overexpression of the p53 gene. It was noted that there was no evidence of disease in the patients at the beginning of the study
 
145 29.5 months metastatic breast cancer 4 Chemotherapy
University Hospital (Vienna) Austria 3/2005
Treatment Details: Patients: This Phase III study involved 259 women with metastatic breast cancer. The patients were randomly placed into two groups: Group A had 124 patients (median age 53). Metastatic si
 
146 29.2 months Malignant Pleural Mesothelioma 3 Chemotherapy
Immunotherapy
Center Hospitalier Intercommunal de Creteil France 6/2002
Treatment Details: Patients: This Phase II study involved 17 patients with Malignant Pleural Mesothelioma. Many of the patients had undergone “preventive radiotherapy.” Treatment: The treatment consisted o
 
147 29.2 months Metastatic breast cancer 5 Chemotherapy
CHU Dupuytren France 7/2009
Treatment Details: Patients: This phase 2 study involved 54 women with HER-2 negative metastatic breast cancer. Their median age was 58.5, ranging from 31 to 84 years old. Treatment: These women were tre
 
148 29.1 months Advanced colorectal cancer 4 Chemotherapy
Kanagawa Cancer Center Japan 10/2010
Treatment Details: Patients: This phase II study involved 38 advanced colorectal carcinoma patients with a median age of 63 years; 21 of the patients were male. Treatment: Patients were treated with the
 
149 29.0 months Diffuse large B-cell lymphoma 5 Biologic therapy
Chemotherapy
Hormone
Centre régional de lutte contre le cancer de Nice France 5/2011
Treatment Details: Patients: This phase II study involved 149 elderly patients with diffuse large B-cell lymphoma (a type of non-Hodgkin’s lymphoma). The median patient age was 83 years (range of 80-95) and
 
150 29.0 months Castration-resistant prostate cancer 4 Chemotherapy
Cancer Center Poland 3/2014
Treatment Details: Patients: This phase 2 study involved castration-resistant prostate cancer patients who were divided into two separate treatment groups. Group A consisted of 98 patients with a median age
 
Page 15 of 187  | Previous Page  | Next Page